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Summary One of the most sensitive hypoxia detection methods is based on the observation that binding of
nitroimidazoles to cellular macromolecules occurs as a result of hypoxia-dependent bioreduction by cellular
nitroreductases. Nitroimidazole-binding techniques provide measurements of hypoxia to virtually any degree
of spatial resolution and with a multiplicity of techniques. This paper demonstrates hypoxia imaging using in
vivo EF5 binding with detection by a fluorochrome-conjugated monoclonal antibody. We investigated these
techniques in the 9L glioma tumour, in part because the exact nature of the hypoxia in this tumour system is
controversial. Our results demonstrate that following intravenous injection of EF5, binding and detection
using a monoclonal antibody in 9L gliomas is specific and oxygen dependent. Detection of binding using
fluorescence microscopy can be performed on frozen tissues; tissue sections can be counterstained with
haematoxylin and eosin for light microscopic analysis. Alternatively, the distribution of hypoxia in a tumour
can be inferred by examining individual tumour cells using flow cytometric techniques. Based upon the results
presented herein, the radiation-resistant phenotype of 9L epigastric tumours grown in our laboratories can be
associated with the presence of hypoxic cells.
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A recent National Institutes of Health (NIH) workshop
emphasised the importance of developing methods to deter-
mine the presence and extent of hypoxia in individual human
cancers (Stone et al., 1993). One of the most sensitive
hypoxia detection methods is based on the observation that
binding of nitroimidazoles to cellular macromolecules occurs
as a result of hypoxia-dependent bioreduction by cellular
nitroreductases. Binding of the nitroimidazole misonidazole
within hypoxic tumour regions has been demonstrated in
many laboratories, (for example see Urtasun et al., 1986)
with rates that decrease over the P02 range that affect radio-
sensitivity (Urtasun et al., 1986; Franko et al., 1987; and see
accompanying manuscript, Koch et al., 1995a). Nitro-
imidazole-binding techniques allow measurements of hypoxia
across individual cell distances and with a multiplicity of
techniques. Early studies utilised '4C-labelled misonidazole
with interpretation based on autoradiographs (Chapman et
al., 1983). Because this method is tedious, time consuming
and not readily applicable clinically, investigators have
sought to develop antibody-based detection techniques
against nitroimidazole compounds. Studies have been per-
formed using antibodies, for example against CCI-103F
(Raleigh et al., 1987; Cline et al., 1994) and 7-(4"-(2-
nitroimidazole-1-yl)-butyl)-theophylline (NITP) (Hodgkiss et
al., 1992a,b). Examination ofbinding has included analysis of
tissue sections stained via fluorescence (Hodgkiss et al., 1991)
and immunohistochemical techniques (Cline et al., 1994).
Flow cytometric techniques to measure binding to individual
cells have also been described (Hodgkiss et al., 1991; Olive
and Durand, 1983). Recently, a monoclonal antibody was
raised against adducts of a pentafluorinated derivative of
etanidazole, [2-(2-nitro-IH-imidazol-1-yl)-N-(2,2,3,3,3-penta-
fluoropropyl) acetamide] (EF5) (Lord et al., 1993) and bind-
ing in tumour cells was visualised using fluorescence
immunohistochemical techniques (Koch et al., 1995a). We
have used this technique to assess hypoxia in an implanted
rat glioma model.
In the mid-1960s, a glioma tumour was induced in a male
CD Fischer rat following weekly injections of N-nitroso-
methylurea. After successive in vivo and in vitro transfers, a
cell line was established (9L) which produced a gliosarcoma
when implanted intracerebrally. Since that time, the 9L has
been used extensively as a subcutaneous and intracerebral
tumour model, especially for studies of radiosensitivity (Leith
et al., 1975; Wallen et al., 1980). Recently, this tumour has
been described as a tissue isolate grown on the epigastric
branch of the femoral vessels (Evans and Koch, 1994).
Typically, intracerebral and small subcutaneous 9L tumours
are characterised as having minimal necrosis and no severe
hypoxia (Leith et al., 1975; Wallen et al., 1980). However the
9L glioma has also been reported to contain uniform or
moderate, intermittent hypoxia (Moulder and Rockwell,
1984; Wong et al., 1990; Franko et al., 1992).
The purpose of this study was to utilise in vivo EF5
binding as detected by a fluorochrome-conjugated mono-
clonal antibody to demonstrate chronic tumour hypoxia. We
chose to investigate these techniques in the 9L glioma
tumour, in part because the exact nature of the distribution
of hypoxia in this tumour system is controversial. Recent
work from our laboratory has confirmed that the oxygen
dependence of binding in 9L (and WNRE cells) is the same
for radioactive and monoclonal antibody-based detection
measurements of drug uptake (Koch et al., 1995a). Further-
more, these studies have indicated that the relative
fluorescence of cells from 9L tumours incubated with EF5
corresponded to the oxygen concentration at which they were
incubated (Koch et al., 1995a).
Materials and methods
Drug synthesis, preparation ofmonoclonal antibodies and EFS
binding-fluorescence assay
These aspects are described in the accompanying manuscript
(Koch et al., 1995a).
Cellpreparation
9L rat glioma cells (Wallen et al., 1980; Franko et al., 1992)
were obtained from KT Wheeler (Bowman Gray School of
Medicine, Winston Salem, NC, USA). Tumours were
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initiated by injection of cells or tissue chunks as described
previously (Evans and Koch, 1994). The dissociation of
tumour cells used previously described methods (Howell and
Koch, 1980; Evans and Koch, 1994) except that 10ml of
enzymatic cocktail (protease, collagenase and DNAase) was
used for tissue samples ranging from 300 to 500mg.
Tumour tissue samples
All animal studies were performed under the regulations of
the University of Pennsylvania Institutional Animal Care and
Use Committee (IACUC). 9L tumours were grown as tissue-
isolated implants on the epigastric artery and vein as des-
cribed previously (Evans and Koch, 1994). The rat was given
EF5 as an intravenous injection of 10mM EF5 prepared in
0.9% saline. The mass of solution administered was 1% of
the rat's mass; thus the equivalent whole-body concentration
was 100 tM. In mice, the whole-body distribution of EF5,
determined using '4C-labelled EF5 at 0.5 h post injection was
very uniform (Laughlin, 1995); similar data in rats are not
available currently. Three hours following EF5 administra-
tion, anaesthesia was induced with xylazine (1.3 mg kg-' i.p.)
and ketamine (140mgkg-'i.p.), the tumour removed and
immediately cooled. The serum half-life of EF5 in rats is
about 150 min, so rapid cooling is necessary to prevent deple-
tion of oxygen followed by binding of residual drug in the
excised tissue (Koch et al., 1993). The tumour was weighed
and then bisected. Half of the tumour was used for disagg-
regation (Howell and Koch, 1980; Evans and Koch, 1994)
and cell analysis (plating efficiency, analysis of EF5 binding
by flow cytometry) and the other half was quickly frozen for
histopathological analysis. The tissue was placed onto a small
piece of saline-moistened filter paper, frozen in ethanol or
isopentane at - 50°C, solvent was rinsed off by immersion for
a few seconds in brine at - 15'C, brine rinsed off by ice-
water slush, and then the still frozen tissue specimen placed
onto solid carbon dioxide pellets. Frozen tissue was stored in
small, closed containers at - 80°C until sectioning.
Tumour sections were cut at 14 ym thickness using a Mic-
rom HM 505 N cryostat and collected onto poly-L-lysine-
coated microscope slides. Staining of the tissue sections was
the same as previously described for whole cells in the
accompanying manuscript (Koch et al., 1995a), except that
rinses were done by moving each tissue section from con-
tainer to container. Note that residual unbound drug is
removed immediately during the fixation stage. Tissue sec-
tions were photographed using a Nikon fluorescence micro-
scope, with a tetramethylrhodamine filter set. A lOx Fluor
objective allowed typical exposure times of 6-400 s with the
100 W high-pressure mercury light source. An infrared cut-
off filter was used for both photography (Kodak Ektachrome
'Elite 400' slide film) and photometry. Photometric analyses
were performed by centring the microscopic field on an
appropriate area of the tissue section being analysed and
then noting the number of seconds that would be necessary
to appropriately expose the Kodak Ektachrome 'Elite 400'
film (Nikon UFX-IIA; large focal spot). These numbers were
then used as a means for comparison of fluorescence intensity
among tumour regions ('photometry'). Photographic slide
images were digitised with a Nikon 'Cool-Scan' and analysed
using the NIH 'Image' software and Adobe Photoshop.
We have found that the fluorescent signal is most stable if
the sections are kept in cold phosphate-buffered saline (PBS)/
1% paraformaldehyde. Since we wanted to be able to photo-
graph both fluorescence and conventional staining of the
same section, a special coverslip system was devised. This
consisted of two strips of mylar film attached to the slide
with glycerol, covered with a haemocytometer coverslip. The
resulting capillary space was filled with PBS/1% parafor-
maldehyde and kept at 4'C and 100% humidity (a conven-
tional coverslip is not strong enough to resist the effects of
moderate desiccation within the capillary space during photo-
graphy at room temperature). Photography of antibody
fluorescence was made at noted vernier locations on the
tissue section. The coverslip was carefully removed after
immersion of the slide in a jar of PBS. The slide was then
removed, air dried and stained with haematoxylin and eosin
(H&E), followed by relocation of the original vernier settings
and conventional photography.
Plating efficiency
For clonogenic assay, suitable numbers of cells were plated
into 100 mm plastic Petri dishes. Each dish contained 9 ml of
Eagle's minimal essential medium (MEM) made with 13%
(v/v) bovine calf serum and 1% antibiotics (Gibco), 'com-
plete medium' and 50 000 feeder cells (feeder cells were
prepared by irradiating 9L cells from tissue culture witl
25 Gy). The number of cells plated was varied over a range
in order to yield 100-200 colonies per plate. In this range,
the number of colonies varies linearly with the number of 9L
cells seeded. Multiple replicates were plated at each of 3-5
dilutions. The plates were incubated for 10-12 days followed
by fixation, staining and counting of colonies.
Irradiation studies
Radiation was performed on an orthovoltage X-ray unit
operated at 225 kVp and 10 mA, 0.2 mm copper filter. The
dose rate was 4.0 Gy min-'. Doses were estimated based on
actual surface dosimetry for each tumour using thermo-
luminescent devices. Hypoxia was induced in tumours by
allowing 10 min following euthanasia before irradiation.
Tumours were irradiated with doses of 0-30 Gy.
Results
Figure 1 illustrates the radiation response of 9L epigastric
implants following 0-30 Gy radiation in air-breathing vs
euthanised rats. Also shown is the radiation response of cells
dissociated from 9L tumours and irradiated as a cell suspen-
sion in room air. In our model, the oxygen enhancement
ratio for a surviving fraction of 1% is 2.9. The radioresponse
of our epigastric tumours in euthanised rats was similar to
that reported by Wallen et al. (1980), when corrected for our
slightly higher plating efficiency: 22% vs 15%. However, the
surviving fraction of tumours irradiated in air-breathing rats
100
00
0
C
0.01~~~~~~~~~
0.001 \
o lo 20 30
Radiation dose (Gy)
Figure 1 Demonstrates the plating efficiency of cells from
epigastric 9L implants following 0-30 Gy radiation in air-
breathing compared with euthanised rats. 9L tumor cells
irradiated in suspension are included for comparison.
euthanised; 0, air-breathing; A, tumour cells irradiated in
suspension. Small dots and solid lines represent data from
unweighted quadratic fit. For euthanised rats, PEOGY= 0.24,
alpha = 0.039 Gy-' and beta = 0.003 Gy-2. For air-breathing
rats, PEOGy = 0.17, alpha = 0.142 Gy-' and beta = 0.001Gy-2.
For cells irradiated in vitro, PEOGy = 0.26, alpha = 0.205 Gy-'
and beta=0.002Gy2.
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- -is substantially higher than that reported by Wallen et al.,
(1980). As discussed below, the presence of significant
hypoxia based on EF5 binding is consistent with this finding.
The distribution of fluorescent binding of EF5 as a
measure of hypoxic heterogeneity in 9L epigastric tumour
tissue sections was studied. Two 9L tumours, representing
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opposite ends of the spectrum of EF5 binding are illustrated.
Tumour A was generally characterised by the presence of
significant binding of EF5 (Figure 2) compared with tumour
B (Figure 3) which had a few areas of EF5 binding but was
generally dim. Evaluation of these tumour specimens was
based upon overall fluorescence intensity patterns of distribu-
2. '-J,*,S,;*F::
Figure 2 Representative fields from tumour A tissue sections. Top (a-d): Tumour was excised 3 h following EF5 administration
and immediately frozen. Fourteen micron tumour sections were stained with Cy-3-conjugated ELK3-51 and photographed with
epifluorescent illumination using a rhodamine filter set. A 10 x Fluor objective allowed an exposure time of 90 s using a 100 W
light source without attenuation. Kodak Ektachrome 'Elite 400' slide film was used. Following photography of the 1050 x 700Am regions, the tumour sections were stained with haematoxylin and eosin and the same sections were rephotographed. (a) 5 s exposure
of a region of widely varying intensity, consistent with the 'Thomlinson and Gray' pattern of binding. (b) 5s exposure of a region
characterised by uniformly intense binding. (c) 5 s exposure of a region characterised by minimal binding. (d) 84 s exposure of same
area as seen in (c) showing that even in relatively oxic regions, variations in binding can be demonstrated. Bottom (e-g)
Haematoxylin and eosin staining of corresponding regions as described for fluorescence photography above. (h) NIH 'Image'
topographical representation of same field as (a).Identification of hypoxia using EF5
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Figure 3 (a) 90s exposure of 14 jim frozen section of 1050 x 700 lim areas of 9L epigastric tumour B as viewed under the
fluorescent microscope. Rat was treated and tissues prepared as described in Figure 2. (b) Corresponding section stained with
haematoxylin and eosin demonstrating a triangular region of hypoxia surrounding necrosis, despite the presence of apparently oxic
tumour in close proximity.
tion. In tumour A the fluorescence distribution patterns are
of two types. In the first type, the intensity varies substan-
tially over several hundred microns oftissue (Figure 2a). This
pattern is characteristic of the 'Thomlinson and Gray' dist-
ribution (Gray et al., 1953; Thomlinson and Gray, 1955) with
variations of fluorescent staining occurring over 100-250 jm
distances, corresponding to known oxygen diffusion ranges in
tumour tissue. The junctional areas between high and low
binding show changes in fluorescence from maximal to
minimal binding over small distances (<100 jim). The
second pattern seen in tumour A is characterised by
moderately to fully hypoxic regions over larger distances
(>>300 jim). The fluorescence distribution in these regions
have larger areas of relatively homogeneous binding (Figure
2b). On H&E sections, this tumour region is relatively
homogeneous with minimal evidence of necrosis (Figure 2f).
Areas of tumour necrosis are relatively uncommon in the 9L
tumours we have studied. However, we have seen regions of
necrosis in some 9L epigastric tumours which have minimal
EF5 binding. Tumour B, illustrated in Figure 3, is charac-
terised by large regions without EF5 binding, apparently oxic
tumour cells. Figure 3 also illustrates that low levels or the
absence of binding is related to two separate and distinct
processes. The first is the presence of viable, oxic cells which
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do not bind EF5 as described above. The second is related to
regions of cell death where the cells are hypoxic but are not
metabolically able to reduce and bind the EF5. Also of
interest in tumour B is the presence of many pyknotic cells in
the region of high binding (Figure 3). Based upon the
number and distribution of these cells, at least some of them
are still able to metabolise EF5.
Figure 4 demonstrates the distribution of fluorescent cells
from the same two 9L epigastric tumours, A and B, as
determined by flow cytometric analysis of fluorescent anti-
bodies specific for EF5 binding. Based upon the dot-plot
distributions (forward vs side scatter), three separate cellular
subpopulations (RI-3) can be identified in both tumours.
Despite the presence ofeach population in both tumours, the
relative numbers of each cellular subgroup varies. Tumour A
has many more cells in the RI region. Previous data from
this laboratory (see Koch et al., 1995a) has shown that there
is little EF5 binding to the RI cells; the exact nature of these
cells (or portions of cells) has not been determined, but they
do not metabolise EF5 when incubated in nitrogen in vitro.
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Population R2 is characterised by cells that are relatively
small in size and complexity, with a median fluorescence of
approximately 15; these cells most likely represent lym-
phocytes. The remaining cells, R3, are generally larger
(higher forward scatter) and have variable complexity (side
scatter) compared with population RI or R2. In tumour A,
R3 contains two distinct cell subpopulations with fluorescent
peaks between 10 and 1000. The average relative fluorescence
of the brightest cells in R3 of either tumour is 500-600
compared with the average relative fluorescence ofthe cells in
R2, which are approximately 10-30 (a contrast between the
most and least hypoxic cells of approximately 16-60 x ). In
addition, the most hypoxic R3 cells (greater than 103 relative
fluorescence) are absent in tumour B; this corresponds well to
the overall appearance of this tumour on fluorescent micro-
scopy which demonstrated only a few regions of moderate
EF5 binding.
Another method for quantification of the overall fluor-
escence intensity, and therefore relative hypoxia, in each
section is to compare the photometry reading in various
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Figure 4 The dot-plot distributions (right) and flow cytometric analyses (left) of cells dissociated from 9L epigastric tumours A and B three hours following EF5 administration, at which time the tumour was excised and dissociated into individual cells. The
upper panels represent data from the tumour shown in Figure 2 and the lower panels represent data from the tumour shown in Figure 3. Based upon the dot-plot distributions, three different cell subpopulations (RI-3) can be identified. Population RI is believed to comprise red blood cells, platelets and tumour debris, explaining minimal EF5 binding. Population R2 is characterised by relatively small size and complexity, has low fluorescence and most likely represents lymphocytes. Population R3 is generally larger in size (higher forward scatter) and has variable complexity (side scatter) compared with populations RI or R2. In tumour A
shown in the upper panel, R3 contains two distinct cell subpopulations with fluorescent peaks between 101 and 103 . For tumour B, lower panel, there are very few cells in the second R3 peak.
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regions of the tumour. In tumour A, the brightest regions
had a photometry reading of 5 s compared with the dimmest
regions where the reading was 84 s. This 17-fold intratumoral
contrast factor within a single tumour section is within the
range of contrast between the brightest and dimmest cells in
the entire tumour, based upon flow cytometric analyses
(16-60x).
Discussion
The 9L glioma has been used extensively as a model for
studies of radiotherapy (Leith et al., 1975; Wallen et al.,
1980). Our data support the resistant nature of the 9L glioma
shown by previous investigators (Leith et al., 1975; Wallen et
al., 1980). The large difference in radiation response between
tumours irradiated under air-breathing conditions in vivo vs
cells from tumours irradiated in suspension under aerobic
conditions suggests the influence of a contact effect and/or
the effect of hypoxia. However, it is unlikely that the contact
effect can explain these results because aerobic cells from
tumours and aerobic cells in tissue culture have the same
radiation response (data not shown). The exact nature of
hypoxia in the 9L has remained elusive. Evidence for
radioresistant hypoxic cells was not found in 9L spheroids
which contained necrotic centres (Gutin et al., 1982). How-
ever, carbogen breathing combined with Fluosol-DA was
shown to sensitise intracranial 9L tumours to radiation
(Teicher et al., 1988). In 1992, Franko et al. sought a more
direct analysis of oxygen concentration using autoradiograms
of 3H-misonidazole (3H-MISO)-labelled 9L tumours and
spheroids. In spheroids, the binding of [3H]MISO varied
inversely to oxygen concentration. Cells adjacent to the nec-
rotic centre bound [3H]MISO, but these cells were found to
be non-clonogenic. In 9L tumours labelled in vivo, the labell-
ing rose gradually from the periphery of the tumour to the
centre and cells adjacent to the rare necrotic areas appeared
to be severely hypoxic.
In 0.05 g intracranial tumours, less than 0.35% (Wallen et
al., 1980) and 0.6-2.6% (Leith et al., 1975) hypoxic cells
were reported. In subcutaneous 9L tumours, hypoxic frac-
tions of 0.9-13% are reported (Wallen et al., 1980). These
data were based upon analysis ofnon-parallel paired survival
curves. As described by Moulder and Rockwell (1984), such
analysis requires several assumptions and therefore, the
hypoxic fraction may not be determined unambiguously.
None the less, these data have been described as being com-
patible with a compartment of 3.1% fully radioresistant,
hypoxic cells or a larger fraction of moderately radioresistant
cells or a mix of moderately and fully hypoxic cells. The data
on EF5 binding presented herein may shed some light on this
question. Two overall patterns of EF5 binding have been
found in 9L epigastric tumours. One type corresponds well to
the patterns expected based upon diffusion and metabolism
of oxygen from individual vessels, 'chronic hypoxia', and
described in the 1950s by Thomlinson and Gray (Gray et al.,
1953; Thomlinson and Gray, 1955). The second pattern is
characterised by moderate hypoxia over several millimetre
distances. These regions are more difficult to explain
physiologically than the 'Thomlinson and Gray' pattern, but
several hypotheses are suggested: episodes of acute hypoxia
(Chaplin et al., 1986); regions of cells with low(er) oxygen
consumption and/or a combination of the capillary distribu-
tion and tumour oxygen consumption. The last situation has
been predicted by Secomb et al. (1993) under conditions of
moderate oxygen consumption (0.23 cm3 02 per 100 gm
min-') and relatively low capillary density, wherein regions
of PO2 less than 1 mmHg are likely. Both the distribution
and absolute brightness of fluorescence seen in our antibody-
stained sections and flow cytometric analysis of cells and
tissues, respectively, suggest extensive hypoxia in the 9L
tumours we have been studying. This is entirely consistent
with the high degree of radiation resistance seen in our lines
irradiated in situ in air-breathing vs euthanised rats. Our data
is internally consistent with a large proportion of moderate
to fully hypoxic cells in these relatively more radioresistant
tumours; we still do not have a complete explanation for the
various theories concerning the degree of hypoxia in 9L
tumours. We know, however, that the binding patterns des-
cribed herein are not restricted to the use of the epigastric
model because the same degree of binding and radioresis-
tance has been found in the subcutaneously implanted 9L
tumour model (Evans and Koch, 1994; and work in pro-
gress). It is possible that the average level of hypoxia, or its
distribution within a tumour varies substantially within
various laboratories. One example of both inter- and intra-
tumour heterogeneity is the interesting pattern of binding
seen in tumour B, Figure 3. In this small triangular region,
with only moderate levels of binding, we find necrosis. Yet,
in tumour A (Figure 2) much larger regions with
undoubtedly much lower oxygen levels remain viable.
Clearly, there are interesting interplays of nutrient presenta-
tion and utilisation throughout these tumours that are not
yet completely understood. Further studies emphasising the
relative location of vasculature vs proliferating and quiescent
cells with hypoxia are under way.
One of the most interesting but troublesome problems in
tumour biology and therapy is the presence of inter- and
intratumoral heterogeneity. Variations in cellular oxygena-
tion (as a result of tumour blood flow) is one of the most
important heterogeneous parameters of tumours because this
characteristic affects pH, nutritional and growth factors,
accumulation of cellular waste products, and energy sources.
The ability to carefully examine and compare the distribution
of cellular oxygenation within individual or in different
tumours is provided by the EF5-binding technique because it
demonstrates variation in binding over cell-cell distances.
For a quick 'snapshot' of the average and distribution of
cellular oxygenation, flow cytometry can be used. In the two
tumours presented here, significant inter- and intratumour
variability in oxygen levels are demonstrated. As well, unique
information on the presence of multiple cellular populations
can be inferred. Both the flow cytometric and fluorescent
immunohistochemical techniques can be extended to inves-
tigate the relationship between hypoxia and other parameters
such as proliferation (Zeman et al., 1993), host cell distribu-
tion (MacDonald and Koch, 1977; Nathan et al., 1982;
Loeffler et al., 1990), vascular distribution (Weber et al.,
1985), apoptosis (Muschel et al., 1995), activation of cellular
regulation factors (for review see Brown and Giacci, 1994)
and hyperthermia (Koch et al., 1995b; Oleson, 1995).
Flow cytometric analysis of EF5 binding provides an
evaluation of the various cell populations and fluorescent
distribution of cell types within the tumour, as well as the
percentage of maximally hypoxic cells. It is of interest that in
both the 9L epigastric tumours shown, three cell populations
(based upon cell size and complexity) were seen. The first
population (RI) bound little, if any, EF5 and most likely
represents cellular debris, red blood cells, platelets, etc. The
second population (R2) is also relatively homogeneous in
size, complexity and EF5 binding. This most likely represents
lymphocytes, based upon known discrimination of normal
blood cell populations using light scattering (size, detected by
forward angle light scattering and granularity, assessed by
side light scattering; Thompson et al., 1985). The third
population of cells are of relatively similar size and complex-
ity but yet are clearly separate populations when analysed for
fluorescence. At this time it is unknown whether these are
two distinct tumour cell populations or whether one of them
represents host cells, such as monocytes or macrophages.
Monoclonal antibody-based studies against rat haemato-
poietic cell surface markers are currently under way. Other
explanations include technical considerations such as the pos-
sibilities of doublets or biological effects such as cell cycle
and metabolism.
One of the many interesting questions that can be ans-
wered using this technique is the fate of hypoxic tumour
cells. Indirect measures of 9L tumour hypoxia give the im-
pression that the 9L tumour contains few hypoxic cells.
However, cells adjacent to the necrotic centre of 9L spheroidsIdentification of hypoxia using EF5
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bound [3H]MISO; in spheroid 'cure experiments' these cells
were not found to be clonogenic (Franko et al., 1992). Con-
versely, however, the hypoxia identified by the EF5-binding
technique is likely to account for the radiation resistance of
the 9L epigastric tumours studied herein. Additional studies
comparing EF5 binding and tumour growth delay would be
necessary to further evaluate this observation. Studies on the
relationship between the presence, distribution and number
of hypoxic cells and their role in tumour persistence are
currently ongoing. The results of such studies would be
expected to vary between tumour types and for individual
tumours within a given type. It is this type of information
that is critical for the evaluation of individual human
tumours in order to predict therapeutic tumour response.
Photomicrographs provide specific information on the dis-
tribution of hypoxic cells and the tumour's overall hetero-
geneity. Our continuing studies are aimed at determining
whether the overall level of hypoxia, as predicted from the
flow cytometric data, correlates with the number, level, and
distribution of hypoxic cells in photomicrographs. It is not
known at this time whether the tumour's average level of
hypoxia, the number of maximally hypoxic cells or the
heterogeneity of these characteristics determine the thera-
peutic response of a given tumour. Indeed, as noted above, in
some tumours the presence of hypoxic cells may not be the
factor which limits survival. As demonstrated herein, the
excellent fluorescent contrast provided by EF5 binding with
monoclonal antibody detection will allow the analysis of
these questions.
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